Works matching IS 03407004 AND DT 2003 AND VI 52 AND IP 6
Results: 7
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 359, doi. 10.1007/s00262-002-0365-4
- By:
- Publication type:
- Article
International conference: Progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 403, doi. 10.1007/s00262-002-0366-3
- By:
- Publication type:
- Article
Interferon-α and interleukin-12 gene therapy of cancer: interferon-α induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 378, doi. 10.1007/s00262-002-0367-2
- By:
- Publication type:
- Article
Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 387, doi. 10.1007/s00262-003-0375-x
- By:
- Publication type:
- Article
A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 367, doi. 10.1007/s00262-003-0376-9
- By:
- Publication type:
- Article
Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 347, doi. 10.1007/s00262-003-0379-6
- By:
- Publication type:
- Article
High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4<sup>+</sup> T cell Infiltration, enables murine skin tumours to progress.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 396, doi. 10.1007/s00262-003-0380-0
- By:
- Publication type:
- Article